590 filings
Page 5 of 30
4/A
Michael T. Constantino
21 Mar 22
9 METERS BIOPHARMA / Michael T. Constantino ownership change
4:17pm
4
NMTRQ
9 Meters Biopharma, Inc.
7 Mar 22
9 METERS BIOPHARMA / Mark A Sirgo ownership change
8:01am
4
Temperato John
4 Mar 22
9 METERS BIOPHARMA / John Temperato ownership change
8:00am
8-K
NMTRQ
9 Meters Biopharma, Inc.
28 Feb 22
9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease
4:22pm
4
Temperato John
23 Feb 22
9 METERS BIOPHARMA / John Temperato ownership change
4:15pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
11 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
SC 13G/A
NMTRQ
9 Meters Biopharma, Inc.
10 Feb 22
9 METERS BIOPHARMA / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
10:35am
SC 13G
NMTRQ
9 Meters Biopharma, Inc.
4 Feb 22
9 METERS BIOPHARMA / BlackRock ownership change
4:12pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
24 Jan 22
9 Meters Biopharma Announces Allowance of Patent for NM-102 in Combination with Immune Checkpoint Inhibitors
8:06am
4
Bethany Sensenig
18 Jan 22
9 METERS BIOPHARMA / Bethany Sensenig ownership change
7:24pm
3
Bethany Sensenig
18 Jan 22
9 METERS BIOPHARMA / Bethany Sensenig ownership change
8:06am
8-K
NMTRQ
9 Meters Biopharma, Inc.
18 Jan 22
9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer
8:05am
8-K
NMTRQ
9 Meters Biopharma, Inc.
3 Jan 22
Other Events
7:38am
4
NMTRQ
9 Meters Biopharma, Inc.
3 Dec 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
7:34am
4
NMTRQ
9 Meters Biopharma, Inc.
22 Nov 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
7:30am
4
NMTRQ
9 Meters Biopharma, Inc.
19 Nov 21
9 METERS BIOPHARMA / John Temperato ownership change
7:31am
10-Q
2021 Q3
NMTRQ
9 Meters Biopharma, Inc.
Quarterly report
15 Nov 21
7:39am
8-K
NMTRQ
9 Meters Biopharma, Inc.
15 Nov 21
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
7:34am
8-K
NMTRQ
9 Meters Biopharma, Inc.
10 Nov 21
9 Meters Biopharma, Inc. Announces Immuno-Oncology Collaboration with Gustave Roussy for NM-102, a Gut Microbiome Modulator
7:33am
8-K
NMTRQ
9 Meters Biopharma, Inc.
26 Oct 21
2021 Annual Scientific Meeting
7:33am